INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 124 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $195,000 | +31.8% | 42,285 | 0.0% | 0.00% | – |
Q4 2018 | $148,000 | -64.3% | 42,285 | +2.8% | 0.00% | -100.0% |
Q3 2018 | $415,000 | +39.3% | 41,140 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $298,000 | +33.0% | 41,140 | +10.8% | 0.00% | – |
Q1 2018 | $224,000 | -38.3% | 37,129 | -1.7% | 0.00% | -100.0% |
Q4 2017 | $363,000 | +8.4% | 37,779 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $335,000 | -37.7% | 37,779 | -11.2% | 0.00% | 0.0% |
Q2 2017 | $538,000 | +10.7% | 42,544 | -8.0% | 0.00% | 0.0% |
Q1 2017 | $486,000 | +9.2% | 46,244 | -4.3% | 0.00% | 0.0% |
Q4 2016 | $445,000 | -24.1% | 48,344 | -2.8% | 0.00% | 0.0% |
Q3 2016 | $586,000 | -7.7% | 49,744 | +1.4% | 0.00% | 0.0% |
Q2 2016 | $635,000 | -20.3% | 49,044 | -1.6% | 0.00% | -50.0% |
Q1 2016 | $797,000 | -36.2% | 49,844 | +14.3% | 0.00% | -33.3% |
Q4 2015 | $1,249,000 | +2.4% | 43,625 | +1.8% | 0.00% | 0.0% |
Q3 2015 | $1,220,000 | -21.0% | 42,871 | -0.2% | 0.00% | -25.0% |
Q2 2015 | $1,544,000 | +45.8% | 42,971 | +135.8% | 0.00% | +33.3% |
Q1 2015 | $1,059,000 | +35.6% | 18,220 | -1.6% | 0.00% | +50.0% |
Q4 2014 | $781,000 | +9.2% | 18,520 | +0.4% | 0.00% | 0.0% |
Q3 2014 | $715,000 | +25.4% | 18,441 | +1.1% | 0.00% | +100.0% |
Q2 2014 | $570,000 | -0.5% | 18,236 | +31.8% | 0.00% | -50.0% |
Q1 2014 | $573,000 | +62.3% | 13,836 | +51.6% | 0.00% | +100.0% |
Q4 2013 | $353,000 | +11.7% | 9,124 | +1.1% | 0.00% | 0.0% |
Q3 2013 | $316,000 | +159.0% | 9,024 | +2.3% | 0.00% | – |
Q2 2013 | $122,000 | – | 8,824 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 3,257,094 | $92,697,000 | 13.04% |
JW Asset Management, LLC | 388,346 | $11,052,000 | 4.00% |
Anson Funds Management LP | 400,200 | $11,390,000 | 3.31% |
Orbimed Advisors | 4,081,800 | $116,168,000 | 1.17% |
SCOPIA CAPITAL MANAGEMENT LP | 1,718,487 | $48,908,000 | 1.05% |
Bellevue Asset Management AG | 210,000 | $5,977,000 | 0.98% |
NEXT CENTURY GROWTH INVESTORS LLC | 788,534 | $22,441,000 | 0.93% |
Rock Springs Capital Management LP | 308,000 | $8,766,000 | 0.71% |
JUNCTURE WEALTH STRATEGIES, LLC | 18,502 | $527,000 | 0.43% |
B. Riley Wealth Management, Inc. | 8,600 | $244,000 | 0.35% |